| Speciality Medicines Ltd |
|
|
| Initial public issue of upto 23,50,000 equity shares of face value of Rs. 10/- each of Speciality Medicines Limited ("SML" or the "Company" or the "Issuer") for cash at a price of Rs. 124 per equity share including a share premium of Rs. 114 per equity share (the "Issue Price") aggregating to Rs. 29.14 Crores ("the Issue"), of which upto 1,50,000 equity shares of face value of Rs.10/- each for cash at a price of Rs. 124 per equity share including a share premium of Rs. 114 per equity share aggregating to Rs. 1.86 Crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. Net issue of 22,00,000 to be updated equity shares of face value of Rs. 10/- each at a price of Rs. 124 per equity share including a share premium of Rs. 114 per equity share aggregating to Rs. 27.28 Crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.75% and 25.04%, respectively, of the post issue paid up equity share capital of the company.
The face value of the equity shares is Rs. 10/- each.
Price Band: Rs. 124 per equity share of face value of Rs. 10 each.
The floor price is 12.40 times of the face value.
Bids can be made for a minimum of 2000 equity shares and in multiples of 1000 equity shares thereafter. |
| Issue |
Money Payable On |
| Opened On |
Closed On |
Offer Price |
Application |
| 20-Mar-26 |
24-Mar-26 |
₹ 124.00 |
₹ 124.00 |
| Minimum Application for shares in Nos :2000 Further Multiples of :1000 |
| |
|
Lead Managers to the Issue |
| Project Cost |
₹ 0.00 Cr |
| Unistone Capital Private Limited |
|
| Project Financed through Current Offer |
₹ 29.14 Cr |
|
| Post Issue Equity Share Capital |
₹ 8.79 Cr |
|
| Face Value |
₹ 10 |
|
|